Starpharma’s Viraleze protects against Covid infection in trials
Starpharma’s Viraleze antiviral nasal spray has passed another trial confirming its effectiveness – this time showing it provides protection against infection with the highly transmissible SARS-CoV-2 Omicron variant of the virus which causes Covid-19. One hundred per cent of animals treated with Viraleze in a viral challenge test by Scripps Research had no detectable virus…